Abstract
A 5 year old boy developed severe weakness after receiving vincristine for treatment of acute lymphoblastic leukaemia. Although weakness improved after the discontinuation of vincristine, other symptoms suggestive of a neuropathy persisted. Neurophysiological and genetic analysis at age 8 years indicated that vincristine had induced symptoms of a hereditary sensory motor neuropathy type 1A, which had previously been asymptomatic; his genetically affected mother was also asymptomatic.
Full Text
The Full Text of this article is available as a PDF (51.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Casey E. B., Jellife A. M., Le Quesne P. M., Millett Y. L. Vincristine neuropathy. Clinical and electrophysiological observations. Brain. 1973;96(1):69–86. doi: 10.1093/brain/96.1.69. [DOI] [PubMed] [Google Scholar]
- Geny C., Gaio J. M., Mallaret M., Goy A., Reymond F., Pegourie B., Yulis J., Perret J. E. Maladie de Charcot-Marie-Tooth révélée par un traitement á la vincristine au cours d'une maladie de Hodgkin familiale. Ann Med Interne (Paris) 1990;141(8):709–710. [PubMed] [Google Scholar]
- Graf W. D., Chance P. F., Lensch M. W., Eng L. J., Lipe H. P., Bird T. D. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer. 1996 Apr 1;77(7):1356–1362. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
- Igarashi M., Thompson E. I., Rivera G. K. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy). Med Pediatr Oncol. 1995 Aug;25(2):113–116. doi: 10.1002/mpo.2950250212. [DOI] [PubMed] [Google Scholar]
- McGuire S. A., Gospe S. M., Jr, Dahl G. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Med Pediatr Oncol. 1989;17(6):520–523. doi: 10.1002/mpo.2950170534. [DOI] [PubMed] [Google Scholar]
- Neumann Y., Toren A., Rechavi G., Seifried B., Shoham N. G., Mandel M., Kenet G., Sharon N., Sadeh M., Navon R. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol. 1996 Apr;26(4):280–283. doi: 10.1002/(SICI)1096-911X(199604)26:4<280::AID-MPO12>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]